CSE Global (Stock 3 Good 3 Bad) | 🦖 #TheInvestingIguana EP1055
🟩 🦖 Are you wondering if CSC Global is a "buy, hold, or sell" for your portfolio? Join Iggy, #TheInvestingIguana, as he breaks down everything you need to know about this Singapore-based systems integrator! In this video, packed with insights, we'll explore CSC Global's strengths, red flags, and why its growing focus on data centers could shape its future. Whether you’re eyeing a stable dividend for your CPF or SRS funds or simply want expert financial analysis, this one’s for you. 📊 Here's what you'll get: • Shedding light on CSC Global’s business segments—electrification, communications, and automation. • The three biggest positives, including the booming data center market and a rock-solid order backlog. • The three major risks, from foreign exchange swings to rising costs and high divi
Alphabet Breaks Out to New Highs – Round Base Completed
Alphabet Inc. ($Alphabet(GOOGL)$ ) – Technical Analysis Chart Pattern: The stock has been forming a round base, gradually building strength over the past months. Breakout: Price has now broken out to an all-time high at 211.64, confirming bullish momentum. Momentum: The breakout from consolidation with increasing strength often signals continuation potential. Next Watch: Sustained closes above this breakout zone would confirm trend continuation. Pullbacks toward the breakout level may act as support. Using DLCs for Short-Term Trading Long DLCs ($ALPHAB 3xLongSG261006(USJW.SI)$ ) : Traders who expect follow-through after the breakout may use long DLCs for leveraged exposure to capture short-term upside
You’ve highlighted three important threads that are converging into September: 1. Extreme VIX Positioning Hedge funds and CTAs have indeed piled into short-volatility trades (short VIX futures, options, and related ETFs). When positioning is this one-sided, it sets the stage for a volatility spike if any shock materialises. It doesn’t necessarily mean VIX will explode on its own — but it does mean the market is more fragile to surprise events (macro data, Fed missteps, geopolitics, or “Trump-Fed drama”). 2. The September Effect Statistically, September has been the weakest month for equities (both in the U.S. and globally), with average negative returns. This tendency is usually attributed to seasonal factors: post-summer rebalancing, mutual fund tax-loss harvesting, and lower liquidity. W
👉 Want to catch today’s live session? Click here to reserve your spot now!Alibaba Group FY2026Q1 Earnings Conference CallSmart ideas deserve to be seen.Drop a trade idea and help others learn. 💬📚Catch up fast:These events rocked the markets today.More NewsTiger Community TOP10 Tickers🎯 S&P500 Most Active Today 👉@TigerObserverWeekly Five Key Areas: Macro, Singapore Stocks, Options, Futures, EarningsCovering five major market segments this week to help you stay ahead of market trends and plan your trades effect
Overall Markets Global equities ended the session on a mixed note as investors digested Nvidia’s earnings, U.S. political headlines, and lingering geopolitical risks. Wall Street closed higher, Europe showed uneven performance, while Asia posted mixed results with strength in Japan and China offset by weakness in Hong Kong. US: Resilience Amid Uncertainty U.S. markets advanced modestly, with the Dow $DJIA(.DJI)$ gaining 0.1%, the S&P 500 $S&P 500(.SPX)$ up 0.3%, and the Nasdaq $NASDAQ(.IXIC)$ climbing 0.5%. Investors weighed signs of economic re
Signet Jewellers (SIG) Capital Allocation and Profitability To Watch
$Signet Jewelers(SIG)$ is scheduled to report its Q2 2026 earnings on Tuesday, September 2, 2025, before the market opens. Sales/Revenue: Analysts' consensus for Q2 2026 sales is approximately $1.50 billion. This is in line with the company's own guidance of $1.47 billion to $1.51 billion and would represent a slight increase from the $1.49 billion reported in Q2 2025. Earnings Per Share (EPS): The consensus EPS target for Q2 2026 is around $1.20, which would be a decline from the prior-year period's $1.25. However, some analysts are more optimistic, with some forecasting a beat, with EPS as high as $1.37. The company's full-year EPS guidance is a wide range of $7.70 to $9.38. Summary of Fiscal Q1 2026 Earnings On June 3, 2025, Signet Jewelers repo
Chow Sang Sang is a hidden gem. As of the closing price on August 28, 2025, its Price-to-Book (P/B) ratio was 0.66. $CHOW SANG SANG(00116)$ The company's assets are primarily current assets (85%), mainly consisting of gold, jewelry, Rolex watches... Inventory asset. I find it hard to believe that such a company exists. Given its consistent dividend payments over the past 15 years and a current Trailing Twelve Months (TTM) dividend yield of 4.95%, I believe the financial statement is real. My conclusion is that the market has overlooked this small business, focusing instead on larger players, like $LAOPU GOLD(06181)$ $CHOW TAI
$Opendoor Technologies Inc(OPEN)$ 🚨 OPEN (Opendoor) Short Squeeze Loading? 🚨 🔥 24% of the float shorted — nearly a quarter of all available shares are being bet against. ⚡ Only 1 day to cover — if the price runs, shorts will have no time to escape. 📈 Stock already up 200%+ in recent weeks, fueled by hype, momentum, and Opendoor’s pivot into AI. 💥 Meme-stock vibes are back. Social buzz + high short interest = the perfect recipe for a gamma + short squeeze combo. 👉 Shorts are trapped. Momentum is building. Don’t be the one watching from the sidelines when this thing rips. #Stocks #OPEN #ShortSqueeze #MemeStocks #AI
Aptorum Group (APM): The Synaptic Leap – Merging Diagnostics and Therapeutics for a Brain Health Boom
In the volatile world of biotech stocks, Aptorum Group Limited (APM) has been a rollercoaster ride, but recent developments signal a transformative ascent. As of August 28, 2025, shares have surged dramatically, with a 159% jump on August 21 alone, closing at $3.29, fueled by key regulatory approvals and strategic mergers. While the market buzzes about short-term gains, the real story lies in a unique synergy: Aptorum’s merger with DiamiR Biosciences isn’t just a business deal—it’s the birth of a “synaptic ecosystem” that fuses cutting-edge diagnostics with targeted therapeutics, positioning APM as the vanguard of a brain health revolution in an aging global population. This isn’t your typical biotech play; it’s a holistic approach that could redefine how we combat neurodegenerative diseas
I’ll be focusing on $CrowdStrike Holdings, Inc.(CRWD)$ after its earnings. Cybersecurity remains a strong growth theme, and CRWD has executed well with ARR growth and enterprise adoption. The key will be whether it can keep upselling more modules and expanding margins. CRWD usually makes big moves post-earnings, so I see volatility as an opportunity. A strong beat could spark a breakout, while any dip on profit-taking might offer a good entry. Long term, cybersecurity tailwinds keep me constructive on the stock. While I’ll watch energy and gold futures, CRWD is my top priorit